Open access

Evaluation of Left Ventricular Diastolic Function by Echocardiography

Written By

Juan Lacalzada, Amelia Duque, Alejandro de la Rosa, Antonio Barragan, María Manuela Izquierdo, Eduardo Arroyo, Ana Laynez and Ignacio Laynez

Submitted: November 11th, 2010 Published: July 5th, 2011

DOI: 10.5772/21051

Chapter metrics overview

12,165 Chapter Downloads

View Full Metrics

1. Introduction

It appears that for some time diastole was taken for granted and largely ignored. Systole was thought of as the only function that truly predicted cardiac risk. The fact that diastolic heart failure (DHF) was referred to at one point as “heart failure with normal ejection fraction (EF)” lends credence to this assumption. It has been proven since that cardiac relaxation is an active energy-dependent process that begins in late systole and extends into early or mid-diastole (Shah & Pai, 1992). The fact that diastolic dysfunction contributes to up to half of the cases of heart failure dispelled the myth that systolic function is the only factor to consider in cardiac risk assessments (Bhatia etal., 2006, Owan etal., 2006, Vasan etal., 1995). Cardiologists are ahead of surgeons in recognizing the importance of diastolic function in clinical practice. They have noticed that changes in diastolic filling pattern are of a prognostic value following myocardial infarction. Left ventricular remodeling following acute myocardial infarction (AMI) is a well known phenomenon occurring in the earliest post infarction phase and continuing for weeks or months. A restrictive transmitral filling pattern which is a marker of diastolic dysfunction provides significant information in these patients. A short initial deceleration time (DT) < 150 ms obtained as early as 1 day after AMI can identify patients who are likely to undergo LV remodeling in the following year (Otasević,2001). Remodeling is a precursor of heart failure and a strong predictor of mortality. Therefore, an early restrictive filling pattern as evidenced by a short DT identifies patients who are likely to develop progressive LV dilation and dysfunction. Persistence of a restrictive filling pattern is the most powerful independent predictor of severe dilation and late mortality (Temporelli etal,,2004, Whalley etal, 2006), The importance of diastolic dysfunction to the surgeon became apparent when it was established that it is a predictor of difficult weaning off cardiopulmonary bypass and mortality (Bernard etal, 2001, Salem etal, 2006). Finally, the impact of diastolic dysfunction affects the anesthesiologist as these patients may tolerate acute preload reduction with induction of anesthesia poorly leading to low cardiac output and hypotension. This patient population presents difficult anesthetic challenges and places these patients at high risk of perioperative morbidity and mortality (Couture etal, 2009 Sanders etal, 2009). In short, diastolic dysfunction has touched every facet of clinical practice. This chapter will predominantly focus on DHF (with normal EF) as distinct to the combined systolic and diastolic failure.


2. Clinical spectrum

Diastolic dysfunction can be defined as the inability of the left ventricle to adequately fill at low or normal atrial pressures unrelated to intrinsic valve disease or pericardial pathology. This dysfunction can result either from an impairment in LV compliance (passive mechanism) or from an alteration in LV relaxation (active process).

Since not all patients who undergo heart surgery have a normal EF, the classical definition of DHF of heart failure with normal EF does not always apply. It is therefore necessary not to overlook the status of the preoperative EF when assessing the DHF in the postoperative heart. With this understanding DHF in the postoperative state is better defined as a clinical syndrome of heart failure with a preserved left ventricular EF in the absence of major valve disease or pericardial pathology (Vasan & Levy, 2000 Vasan, 2003). It is associated with abnormalities of diastolic distensibility, filling, or relaxation of the left ventricle (Gaasch & Zile, 2004) clinically; DHF is usually accompanied by severe reduction of exercise capacity, neuroendocrine activation, and poor quality of life. Typically the ventricle has thick walls and a small cavity (increased left ventricular mass/volume ratio) (Kitzman etal, 2000). In contrast to systolic heart failure, DHF affects women more frequently. DHF can occur alone or in combination with systolic heart failure. In isolated DHF (characterized as a small stiff heart), the only abnormality in the pressure-volume relationship occurs during diastole, when there are increased diastolic pressures with a low end diastolic volume. In systolic heart failure, the abnormalities in the pressure-volume relationship during systole include decreased EF, stroke volume and stroke work. If there are in addition, changes in the diastolic portion of the pressure-volume relationship that leads to increased diastolic pressures, the implication then is that there is both systolic and diastolic cardiac failure (Zile &, Brutsaert, 2002; Deswal, 2005; Burkhoff etal. 2003).These concepts are depicted in Figure 1, using simplified pressure-volume loops, and showing the left ventricular end-diastolic pressure-volume curves. The normal left ventricle is shown with (LVEDP) < 16 mmHg. For DHF, the loop is smaller indicating reduced stroke volume, and shifted up and to the left, with LVEDP > 16 mmHg. It is important to note, that the end-diastolic volume in DHF is at the lower range of normal. In contrast, the end-diastolic volume in patients with systolic failure is increased.


3. Mechanics of diastole

Ventricular relaxation is an active energy-dependent process that begins in late systole and extends into early or mid-diastole (van Kraaij et al.2003). Relaxation can be defined as the time period during which the myocardium loses its ability to generate force and further shortening, and returns to an unstressed length and force (Zile &, Brutsaert, 2002) Diastole begins at the closure of the aortic valve and lasts until closure of the mitral valve

Figure 1.

Pressure–volume loop diagram indicating the position of the end-diastolic pressure–volume on curve for DHF; normal diastolic function (Normal); systolic failure (SF), and systolic and diastolic failure (S+DHF). A horizontal dashed line at >16 mmHg indicates division between normal and raised end-diastolic pressure. Adapted with permission from Elsevier Publishing (Alsaddique etal 2009]

(Kawaguchi et al, 2003). Broadly speaking, diastole can be looked at as two phases; isovolumetric relaxation corresponds to LV pressure decline at constant volume, that lasts from the closure of the aortic valve to opening of the mitral valve. The second phase is auxotonic relaxation corresponding to LV filling lasting until closure of the mitral valve. LV filling depends mainly on the pressure gradient between the LA and LV which is influenced by ventricular compliance, active relaxation, and augmented by atrial contraction towards end-diastole. Traditionally however, diastole is divided into four distinct phases: isovolumetric relaxation, early rapid ventricular filling, diastasis and atrial systole. The isovolumic relaxation time is a continuum of systole and is dependent on it. The early rapid ventricular filling phase is dependent on LV relaxation and compliance. Diastasis is dependent on both the heart rate and chamber compliance. The atrial contraction depends on the chamber compliance, left atrial (LA) function and the conduction system of the heart. At the cellular level, diastole begins when adenosine triphosphate hydrolyzes and actin-myosin cross bridges unlink, leading to sarcomeric relaxation. This is related to decreases in cytoplasmic Ca2 + and the subsequent dissociation of Ca2 + from troponin C. The majority of cytosolic Ca2 + is actively resequestered into the sarcoplasmic reticulum via the sarcoplasmic reticulum Ca2 +ATPase (SERCA2). The remaining cytosolic calcium is removed by the sarcolemmal sodium calcium exchanger and other mechanisms (Groban, 2005). Diastolic function depends on the passive elastic recoil properties of the LV as well as active relaxation. Impaired active myocardial relaxation causes a slow decline in the left ventricular intracavity pressure. The mitral valve opens later, as left atrial filling needs to increase in order to provide a positive gradient across the mitral valve. In severe cases, an increased left atrial pressure state is developed so as to exceed the (increased) left ventricular intracavity pressure (Aurigemma & Gaasch, 2004). An increase in passive chamber compliance can also produce the same pattern and result in elevated LVEDP, thereby necessitating an increased left atrial pressure to provide a driving gradient (Zile et al, 2004). The mechanisms that cause diastolic dysfunction are multifactorial (Kiss etal, 2004). However, they can be broadly categorized as intrinsic (that is affecting the ventricular muscle) or extrinsic (any process that can cause external compression of the left ventricle). A summary of these causes is shown in Table 1. Whilst many of these causes are not reversible in the short term, it is important for clinicians to understand potentially reversible causes so that they can be readily identified and treated. An example of extrinsic pathology is a distended abdomen caused by dilated stomach and bowels actively pushing on the diaphragm, compressing the heart and interfering with cardiac filling, thereby leading to or exacerbating the development of DHF. The major factors that affect diastolic function are ventricular relaxation and compliance. Other factors that influence diastolic function to a lesser degree include systolic function, left atrial pressure, the pericardium, and intrathoracic pressure (Wu &Yu, 2005). In diastolic dysfunction relaxation abnormalities appear early and the inability of the left ventricle to fill in early diastole significantly affect the rapid filling phase resulting in a compensatory increase in filling with atrial contraction. The other factor that determines LV filling is chamber compliance (distensibility of the ventricles), defined as the change in volume over the change in pressure (dV/dP). It can be derived using the relationship between changes in end diastolic pressure (EDP) and end diastolic volume (EDV) by using the formula:

Compliance = Δ EDV / Δ EDP (Gilbert &,Glantz, 1989; Lewis &, Gotsman, 1976)

When ventricular compliance begins to decrease the EDP rises, but the EDV remains unchanged. The increase in EDP reduces the pressure gradient across the mitral valve leading to reduced ventricular filling culminating in decreased cardiac output. Diastolic relaxation is more sensitive to ischemia than systolic contraction, and may lead to subtle relaxation abnormalities without systolic impairment (Garcia-Fernandez etal, 1999). In coronary artery disease, ventricular relaxation as reflected in the early diastolic filling rate may be impaired at rest.


4. Contributing factors

Primary diastolic failure is typically seen in patients with hypertensive or valvular heart disease as well as in hypertrophic or restrictive cardiomyopathy but can also occur in a variety of other clinical situations. The main risk factors for this form of heart failure are advancing age, hypertension, and diabetes mellitus (- Zile & Gaasch 2001). There is a high incidence of diastolic dysfunction among normotensive patients with diabetes mellitus (Boyer etal, 2004). Increased matrix collagen, interstitial fibrosis, myocardial microangiopathy, and myocytes hypertrophy are common findings in the diabetic heart that can lead to diastolic dysfunction. Tight glycemic control decreases the risk of heart failure in patients with diabetes (Iribarren etal, 2001; Liu etal, 2001).The defect in DHF is a combination of impaired ventricular relaxation and a decrease in passive ventricular distensibility (Aurigemma & Gaasch, 2004; Zile etal, 2004). The low cardiac output associated with DHF is due to inadequate ventricular filling, not impaired systolic contraction, and is an important point to remember when managing these patients. LV filling depends mainly on the pressure gradient between the LA and LV which is influenced by compliance, active relaxation, and at end diastole by atrial contraction (Appleton etal, 2000). There are number of predisposing factors that can contribute to DHF in the postoperative cardiac surgical patient. The mechanisms by which these factors exert their

Intrinsic causes
Delay in active relaxationAny cause that interferes with myofilament cross-bridge detachment. Includes poor calcium sequestration, abnormal calcium sensitivity, myocardial ischemia, abnormal sodium/calcium exchanger or alteration in the myocyte calcium-handling proteins
Abnormal “cardiac spring”During contraction, molecular springs such as Titan molecules are compressed, and during diastole contribute to chamber expansion via mechanical elastic recoil. Abnormalities of these molecules may cause diastolic heart failure. It also underlines the importance of systolic function in early diastolic recoil.
Myocardial fibrosisAbnormalities of collagen, or other infiltrative processes (such as amyloid), may increase ventricular wall stiffness by a variety of mechanisms
Left ventricular hypertrophyThis is associated but not necessarily causative of diastolic dysfunction. Chronic increased load such as hypertension or aortic stenosis may also cause changes in collagen composition.
Acute myocardial ischemiaActive relaxation is highly energy dependent, and acute myocardial ischemia will lead to (reversible) diastolic dysfunction
Extrinsic causes
Right ventricle pressure or volume overloadThe right ventricle physically compresses the left ventricle. In severe cases, the left ventricle becomes D-shaped rather than O-shaped. Any course of pressure or volume overload, including pulmonary hypertension will exacerbate left-sided diastolic dysfunction.
PericardiumPericardial fluid or restrictive pericardial disease will limit ventricular filling or physically compress the left ventricle.
Pleural fluidA large pleural effusion may compress the heart
Hyper inflated lungsPressure from the lungs is transmitted via the pericardium to the heart. Severe lung hyperinflation mimics pericardial tamponade. High levels of PEEP are similar.
Distended abdomenFluid, fat, or gaseous distension can cause myocardial compression, particularly in the supine patient

Table 1.

Causes of diastolic dysfunction

effect are briefly explained. Atrial fibrillation is a common occurrence in the postoperative period. It causes loss of atrial contraction that results in impaired diastolic filling. Myocardial hypertrophy is another predisposing factor found in some of the valvular lesions and in hypertensive patients. Its presence interferes with the passive late phase of diastolic filling of the LV contributing to diastolic dysfunction. Myocardial ischemia in the postoperative cardiac surgical patient significantly slows active myocardial relaxation during early diastole. It may also lead to rhythm disturbances that will further aggravate LV diastolic dysfunction. Tachyarrhythmias impair LV filling by shortening the diastolic phase of the cardiac cycle resulting in impaired LV filling (- Zile & Brutsaert, 2002). The effect of positive pressure ventilation (to which virtually all of open heart surgery patients are subjected to postoperatively) on cardiac performance is complex involving changes in preload and afterload for both right and left ventricles. Positive pressure ventilation can lower ventricular filling, and may also reduce afterload, enhancing ventricular emptying during systole. The effect on cardiac output depends on whether the effect on preload or afterload predominates. If the patient is normovolemic and intrathoracic pressure are within normal the effect on afterload reduction predominates resulting in an increase in the cardiac output. The increase in stroke volume leads to increase in systolic blood pressure during lung inflation results in a phenomenon known as reverse pulsus paradoxus. The beneficial effects of positive pressure ventilation on cardiac output are reversed by hypovolemia leading to decreased cardiac output and hypotension (Pinsky, 2005 2007)]. Pericardial constriction or tamponade causes increased resistance to diastolic filling and physiologically is “acute severe extrinsic diastolic failure” whereby the heart becomes physically compressed by the pericardial effusion. Renal insufficiency results in volume overload that leads to a slowing of myocardial relaxation potentially contributing to DHF (Tsuyuk etal, 2001). Chronic anemia is usually accompanied by an increase in cardiac mass due to volume overload. In the animal model, chronic anemia resulted in increased left ventricular end-diastolic pressure and decreased functional reserve which in turn can lead to diastolic dysfunction. It can also lead to tachycardia that it turn shortens diastole resulting in diastolic dysfunction. The anemia that is seen in the postoperative period due to excessive postoperative blood loss is transient, acute and is often rapidly corrected in these patients leading to very little if any effect on the diastolic function (Rakusan, etal 2001). Chronically uncontrolled hypertension is by far the most common predisposing factor in for DHF. It can lead to DHF through a number of ways; one of them is by causing LV hypertrophy that can results in a delayed LV relaxation with all its attendant effects on diastolic filling. The other mechanism is related to a reduced arterial compliance that can also contribute to diastolic dysfunction (Mottram etal, 2005). Hypertension that is seen at times in the postoperative period is usually transient is quickly managed and therefore does not pose the same risk of the more common form of hypertension. At times one may need to pace the heart in the post operative period; as most pacing wires placed at surgery are ventricular, pacing under these circumstances would affect diastolic filling bringing about diastolic dysfunction or could even trigger DHF in some instances. This is largely due to the loss of the atrial contribution to LV filling (Alsaddique, 2008). It is therefore better to keep this possibility in mind and make the extra effort of placing both atrial and ventricular wires for sequential pacing. There seems to be some evidence that Nitric Oxide (NO) metabolism plays a role in acute diastolic dysfunction following episodes of ischemia and reperfusion. It is thought that NO could have a beneficial role as pretreatment with cyclic guanosine monophosphate (cGMP) donors, or with NO donors protects myocytes from relaxation failure in animal models (Schlüter etal, 1994; Draper & Shah, 1997 ; du Toit etal, 1998).


5. Assessment of diastolic function

5.1. Echocardiography evaluation

Transthoracic echocardiography (TTE) or transesophageal echocardiography (TEE) play a major role in the assessment of diastolic function. A combination of 2-dimensional echocardiography, pulsed wave Doppler, Color M-mode (CMM) and Tissue Doppler imaging (TDI) are used in combination to categorize the grade of diastolic dysfunciton.

2-D echocardiography is used to assess ventricular dimensions, LV mass, EF and LA size. Pulsed wave Poppler (PWD) measures the velocity of blood at the cursor position. The mitral inflow Doppler spectral display is composed of an E (early) wave for passive diastolic filling followed by an A (atrial) wave for atrial systole. Mitral blood flow is affected by LV relaxation, LV compliance, and the LA-LV pressure gradient. PWD is used to assess transmitral flow velocity recording and pulmonary vein flow velocity variables in the evaluation of diastolic dysfunction (Hunt etal, 2001; Vasan & Levy, 2000). The four useful variables from mitral flow are: peak early diastolic transmitral flow velocity (E), peak late diastolic transmitral flow velocity (A), early filling deceleration time (DT) and A wave duration [Adur] (Myśliński etal, 2002; Appleton etal, 1988). A normal E/A ratio is considered to be between 0.75 and 1.5. Early filling DT reflects LV compliance in early diastole. The normal DT is usually less than 200 milliseconds in young patients and may exceed 200 ms in patients over 60 years of age (Garcia etal, 1998). Pulmonary venous (PV) flow is composed of systolic and diastolic waves, and an atrial contraction reversal wave. The normal patterns is systolic predominance, but this is reversed when the LAP is elevated. In high LAP, the atrial reversal wave increased in duration such that it exceeds the mitral A wave duration. The major problem with the use of PV flow variables is the difficulty in obtaining adequate measurement when using TTE. The Doppler flow parameters are influenced by a variety of factors including altered loading conditions and heart rate, and not all patients “fit the pattern” (Appleton etal, 2001; Pirracchio etal, 2007). In the operative and critical care settings, the loading conditions and heart rates change frequently, and the patterns may alter without significant change in chamber compliance. Therefore, the results from these measurements may be inconsistent and accordingly inconclusive in the postoperative cardiac surgical patient. Color M-mode (CMM) Doppler flow propagation velocity (Vp) is an easily obtained diastolic index. It displays velocity information a long a line that extends from the mitral valve to the LV apex, providing superior temporal resolution (5 milliseconds), spatial resolution (1mm) and velocity resolution (5 cm/s). The commonly used variable for CMM Doppler is the Vp into the LV which is the velocity at which the blood travels from the mitral valve to the LV apex. In sinus rhythm CMM is characterized by 2 distinct waves, one corresponds to the E wave and the second one to the A wave.

Vp relates well to LV relaxation and is claimed to be relatively load independent. A Vp value of less than 45 cm / s is consistent with diastolic dysfunction in patients older than 30 years of age < 55 cm/s in patients less than 30 years of age (Onose etal, 1999; Dumesnil, etal, 1991). However, a major limitation of Vp is that it is heart rate dependent and in the perioperative setting, heart rate changes frequently.

Tissue Doppler imaging (TDI) is an ultrasound imaging modality that directly measures myocardial velocity during the cardiac cycle and allows wall movement to be directly analyzed (Vitarelli &, Gheorghiade, 1998; Dokainish, 2004). The myocardial portion commonly studied is above the mitral annulus at either the septal or lateral walls. Three wave forms are described, Peak systolic wave, early diastolic wave (Ea) and the end diastolic wave (aʹ) related to the atrial contraction. The Ea wave is relatively independent of loading state and is used to assess LV relaxation, a cut off of 8 cm /s for septal Ea or < 10 cm/s for lateral wall Ea measurement is now widely accepted as a sign of diastolic dysfunction (Sohn etal, 1997). It is easy to perform and available in the majority of patients even if the 2-D imaging is poor, and holds promise as a method to quantify change in diastolic function. When measuring TDI, Khouri and associates measure only early diastolic myocardial velocity (eʹ) at the lateral corner of the mitral annulus, because it has been noted that the lateral annular velocity is more reproducible than the septal annular velocity (Khouri etal, 2004). Figure 2 reveals Echocardiographic findings typical of DHF pattern. Transthoracic echocardiography (TTE) is not always possible in the postoperative situation, due to hemodynamic instability, mediastinal air, the close proximity to a fresh surgical wound, presence of drains and dressings, or due to the inability to position the patient in an optimum way. In addition, mechanical ventilation with high positive end-expiratory pressure, pacing wires, ECG leads further add to the obstacles for the desired examination window resulting in a poor image quality.

Figure 2.

Typical diastolic failure (small stiff heart) typically Grade 2 American Society of Echocardiography (ASE).This is a common pattern in the periopertive setting. Typically Cardiac Index (CI ) 1.8-2.2 l/min/m2 Pulmonary Artery Wedge Pressur( PCWP) > 15 mmHg

5.2. Use of Transesophageal Echocardiography (TEE)

TEE has a well established role in cardiac surgery as it has proved to be a valuable tool for intraoperative decisions particularly in valve surgery (Eltzschig etal, 2008). In addition, it has also proved to be useful in the field of intensive care for the assessment of hemodynamics and to track its variations after therapeutic interventions. Repeated measurements of left ventricular end-diastolic dimension are recommended in order to accurately track the hemodynamic changes, as a single determination is not felt to be reliable. TEE can adequately assess right ventricular function and left ventricular filling pressure using combined Doppler modalities (Vignon, 2005). The same parameters that are described for assessing diastolic function utilizing TTE can be achieved using TEE (Groban& Dolinski, 2005; Klein etal, 1999) though caution should be exercised as many of the Doppler parameters have not been extensively validated in sedated and ventilated patients.

5.3. Identifying a high left atrial pressure

A simple way to conceptualize diastolic failure is to recognize that if high left atrial pressure is present, then clinically important diastolic failure is present, as the body has had to adapt to a stiff ventricle by raising the LAP sufficient to provide an adequate transmitral driving gradient to fill the LV. Figure 3 High LAP can be diagnosed by invasive monitoring (such as a pulmonary artery catheter), or non-invasively with TTE or TEE. A simple pattern that can be easily recognized is that of a tense left atrium, evident by a fixed curve of the interatrial septum pointing from the left to the right atria. When the LAP is normal, the interatrial septum changes direction to point to the left atrium during mid-systole. Once a high LAP is detected, then echocardiography is focused on the chamber dimensions and EF to determine if it is DHF (small LV with normal EF), or systolic and diastolic failure (large heart with reduced EF).

Figure 3.

Flow chart to categorize diastolic dysfunction. Clinically important diastolic failure is associated with raised left atrial pressure. Diastolic dysfunction with normal left atrial pressure does not usually affect hemodynamic stability.The key is to identify high LAP and then identify if the LV volume is small to normal or dilated, in order to differentiate primary diastolic failure form systolic and diastolic failure.

5.4. Natriuretic peptides

B-type Natriuretic peptide (BNP) is a marker of systolic left ventricular dysfunction and heart failure. It however increases in subjects with diastolic dysfunction (mean 20.3+/-4.7 pg/ml vs. control 9.6+/-0.5 pg/ml, p<0.001). A normal BNP level virtually excluded the presence of diastolic dysfunction and concomitant left ventricular hypertrophy (LVH). Increased BNP concentrations in subjects with diastolic dysfunction are strongly related to LVH (Lukowicz etal, 2005).] In patients with normal systolic function, elevated BNP levels and diastolic filling abnormalities might help to reinforce the diagnosis diastolic dysfunction (Lubien etal, 2002; Krishnaswamy etal, 2001) A-type atrial, natriuretic peptide (ANP) is secreted from the atria in response to dilatation. Brain-type (B-type) natriuretic peptide (BNP) is a neurohormone that is released by the cardiac myocytes when left ventricular wall stress increases. After secretion the pro-hormone is cleaved to the biologically active hormone (BNP) and an inactive N-terminal fragment (N-BNP) Plasma levels of BNP increase in direct relation to increase in ventricular end-diastolic volume and end-diastolic pressure of both right and left side(Stewart, 2005). A rise in BNP produces vasodilatation and increase in renal sodium excretion (Maisel etal, 2002). Atrial natriuretic peptide and brain natriuretic peptide are known to be indices for heart failure. Postoperative ANP plateaus on the third postoperative day and decreases gradually down to the preoperative level by one month Postoperative BNP plateaus, showing very slow decrease and it never returning to the preoperative level (Song etal, 2004; Bail etal, 2004)]. This pattern of changes in the BNP and ANP levels after cardiac surgery makes it rather impractical to use them as markers for heart failure in the immediate postoperative setting of these patients.

5.5. Cardiac catheterization

The characteristic finding of DHF is an elevated left ventricular end diastolic pressure (LVEDP) over 16 mm Hg in the presence of a normal LV chamber size (van Heerebeek etal 2006; Kitzman etal, 2002) Vasan and Levy recommended cardiac catheterization as a prerequisite for making the diagnosis of a definite DHF (Vasan & Levy 2000). In the post-operative setting of a fresh open heart surgery cardiac, catheterization is probably not warranted and the diagnosis can be made by less invasive means.

5.6. Multidetector CT (MDCT) of the heart

Cardiac MDCT is most commonly performed for the purpose of noninvasive cardiac angiography. Image data are acquired continuously during a single breath-hold scan, typically 10 to 15 seconds in duration. Contrast is required for angiography and for endocardial border definition, with typical doses in the range of 60 to 80 mL per scan, quite comparable to a diagnostic cardiac catheterization. Patients with cardiomyopathies of all etiologies represent a large and growing population that stands to benefit from advanced imaging techniques (Sibley & Lima, 2008). Electron-beam computed tomography (EBCT) has been shown to be a reliable tool for the assessment of ventricular diastolic function and to detect constrictive filling pattern (Kloeters etal, 2008; Rumberger, 2000). These tools cannot be utilized in the assessment of the post operative heart for logistical reasons

5.7. Cardiac magnetic resonance

Cardiac magnetic resonance (CMR) is the latest addition to the diagnostic tools. The specific advantage of cardiac magnetic resonance (CMR) over echocardiography is the possibility to acquire images in any selected plane or along any selected axis. A routine CMR examination in the setting of heart failure will acquire short access images covering the entire heart from base to apex in addition, to the long access slices. It can also provide a range of LV filling parameters almost similar to those obtained by echocardiography (Rademakers & Bogaert, 2006; Hauser etal, 2004). CMR is considered as a valid alternative for echocardiography when an adequate echocardiographic assessment cannot be obtained. It is the diagnostic modality of choice for assessing small changes in LA or LV volumes and in LV mass (Rademakers, 2003). Clinical use of CMR is expanding and starting to address diastolic LV dysfunction. It is not of course practical to obtain CMR in the fresh postoperative cardiac surgical patient suspected to have DHF.


6. Diagnosis of DHF in postoperative heart

In an ICU environment, the diagnostic criteria are usually based on invasive hemodynamic measurements. As ventricular compliance begins to decrease, the end-diastolic pressure (EDP) rises but the end-diastolic volume (EDV) remains unchanged. The increase in EDP reduces the pressure gradient necessary for ventricular filling and this eventually leads to a lower EDV resulting in a decrease in cardiac output via the Frank-Starling mechanism. The usual method of assessing cardiac failure by the relationship between ventricular filling pressure and stroke volume does not distinguish between systolic and DHF. The end-diastolic pressure (EDP) is elevated in both types of heart failure. The end-diastolic volume (EDV) is increased in systolic heart failure and is decreased in DHF thus it is the parameter that will distinguish systolic from DHF (Aurigemma & Gaasch, 2004). The measurement that is most often utilized to distinguish between diastolic and systolic heart failure is the EF. The EF is normal or near normal in patients with DHF and is reduced in systolic heart failure.

Pulmonary artery catheter with a fast response thermistor can measure the EF of the right ventricle. These catheters are able to register the temperature (T) changes during each cardiac cycle. The change in temperature is due to dilution of the indicator fluid by venous blood that fills the ventricle during diastole. The amount of blood that fills the ventricle during diastole is equal to the stroke volume, the temperature differences between each plateau on the curve (T1 – T2) is the thermal equivalent of the stroke volume (SV) (Figure 4). Temperature T1 is the thermal marker for end-diastolic volume (EDV). The EF becomes equivalent to the ratio T1 – T2 / T1 or [SV/EDV] (Spinale etal, 1990,1991). Once the EF is measured the stroke volume can be calculated by dividing the cardiac output by heart rate. The EDV can be determined by rearranging the EF formula EDV = SV/ EF. The normal RV Right ventricular (RV) EF using thermodilution method is 0.45 to 0.50 which is about 10% lower than the EF measured by radionuclide imaging (Kay etal, 1983). The accepted normal for RVEDV is [80 to 140ml/m2] (Siniscalchi etal, 2005).

The chief points to help in the diagnosis of DHF in the postoperative heart are: (1) Hemodynamic evidence of heart failure (2) Mean pulmonary capillary wedge pressure >12 mmHg (Paulus etal, 2007) (3) Echocardiographic evidence of raised left atrial pressure (LAP) as evidenced by a distended LA with the interatrial septum displaying a fixed curvature towards the right atrium (Kusumoto etal 1993; Royse etal, 2004). (4) Echocardiographic evidence of a small LV in the absence of hypovolemia and valvular heart disease (5) Low EDV as determined by the pulmonary artery catheter (6) EF better or similar to the preoperative one. Table 2.

Increased PACWP
EF Preop a
Evidence of raised LAP a
Small LV a
Low EDV b
Absence of significant pericardial effusion a
a Revealed by echocardiography. b As determined by pulmonary artery catheter.

Table 2.

Features that would suggest DHF in a postoperative heart.PACWP: pulmonary artery capillary wedge pressure; CI: cardiac index; LAP: left atrial pressure; EF:; EDV: end diastolic volume. Adapted with permission from Elsevier Publishing (Alsaddique, 2008)

Indeed according to the European criteria, a normal cardiac index in the face of pulmonary edema suggests DHF (Paulus et al, 2007). Echocardiography is a useful tool to diagnose DHF. In the postoperative heart suspected to have DHF it is not always possible to get an adequate assessment. In addition, air trapped within the postoperative mediastinum creates poor acoustic windows through which ultrasounds waves cannot pass. An echocardiography study that would simply establish that the left ventricular function has not deteriorated compared to the preoperative one and rules out the presence of cardiac tamponade or significant pericardial effusion can usually be done and would probably suffice under the circumstances. If the hemodynamics allow, one can probably use TEE to diagnose of DHF, it remains however an invasive procedure that should only be carried out by an experienced operator. Published guidelines for performance of TEE should be followed (Nihoyannopoulos et al, 2007; Cheiltin et al, 2003; Benjamin et al, 1998). The information gained by TEE should be integrated with the rest of the hemodynamic parameters (pulmonary artery occlusion pressures or pulmonary artery end-diastolic pressures), LA dimensions, and conventional Doppler imaging of mitral inflow in conjunction with TDI of the lateral mitral annular wall.

Figure 4.

Thermodilution EF for the right ventricle.TB baseline blood temperature.T1,T2 andT3 are successive temperature plateaux. (Adapted with permission from Elsevier)

As it has been determined that objective measurement of LV diastolic function serves to confirm rather than establish the diagnosis of DHF. The diagnosis of DHF can be assumed without the measurement of the various parameters that reflect LV diastolic function in the presence of acute pulmonary edema associated with indirect signs of elevated left atrial pressure (Zile etal, 2001).


7. Perioperative management of DHF

Management begins by anticipating the problem before it actually happens. In the preoperative period, it is important to identify patients who may have or are at risk of DHF. Any prior history of DHF is important to identify and attention should be paid to patients who are likely to develop it in order to prevent any further deterioration of diastolic function in the post operative period. Chronically uncontrolled hypertension is a common cause of DHF it should be sought and aggressively treated prior to surgery to reduce the risk of perioperative heart failure (Kostis etal, 1997). Hypertension leads to DHF because of LV hypertrophy and decreased arterial compliance (Mottram etal, 2005). Diabetes mellitus, especially with poor glycemic control, is independently associated with abnormal LV relaxation, is similar in severity to that associated with systemic hypertension. The combination of diabetes and hypertension is associated with greater abnormality than patients with either condition alone. Aggressive control of diabetes, as well as of hypertension, should be considered an important component of the management in the pre operative period. Tight glycemic control decreases the risk of heart failure in patients with diabetes (Iribarren etal, 2001; Liu etal, 2001), It is helpful to avoid hypovolemia, tachycardia and tachyarrhythmias as they impair LV filling by shortening the diastolic phase of the cardiac cycle resulting in suboptimal LV filling (Zile & Brutsaert, 2002). Any reversible predisposing factors is to be corrected prior to surgery. Echocardiography is helpful in the preoperative assessment of patients especially those with compromised cardiac performance in order to identify the nature of heart failure. Risk factors for DHF include elderly patients, the female gender, hypertension, increased left ventricular mass, diabetes, obesity, and ischemic heart disease (Klapholz etal, 2004)


8. Intraoperative and postoperative management

The key to managing DHF is to maintain preoperative parameters as closely as possible. Managing DHF is analogous to walking on a tightrope. Any minor deviation from the “normal parameters tightrope” could lead to hypotension and low cardiac output, or pulmonary venous congestion. The second key principle is to maintain operating volume. As shown in Figure 1, the left ventricle with DHF operates at “just adequate” volume. If the volume is reduced, then a marked reduction in stroke volume will occur leading to low cardiac output and hypotension. It is also important to realize that it is difficult to achieve normal volume in DHF because of the relaxation abnormality. Although the left ventricular volume appears low, it is in the setting of an elevated left atrial pressure. Management of DHF is therefore a process of maintaining a delicate balance and avoiding the contributing and triggering factors that can lead to poor hemodynamic outcome. A summary of these contributing factors is shown in Figure 5. Reduced LV volume (such as blood loss or vasodilation) rapidly leads to hypotension. Tachycardia shortens the diastolic filling time, thereby reducing left ventricular volume and stroke volume (Zile & Brutsaert, 2002). High-dose inotropes initially may increase blood pressure, but as tachycardia ensues, it would cause progressive reduction in left ventricular volume producing a hyperdynamic empty ventricle. High levels of positive end expiratory pressure (PEEP), obesity, pericardial or pleural effusions cause extrinsic compression of the heart and worsen diastolic function. Conversely, excessive administration of fluid in an attempt to improve cardiac output may not produce an increase in stroke volume but will produce an increase in end-diastolic pressure. This may exacerbate pulmonary venous congestion. Excessive hypertension or vasoconstriction will reduce EF and increase left ventricular end-diastolic volume. This has the effect of shifting up the end-diastolic pressure-volume curve where a small increase in volume will produce a large increase in end-diastolic pressure, increasing the risk of pulmonary edema. Bradycardia increases diastolic filling time, and will lead to an increase in the peak LVEDP. DHF can lead to pulmonary hypertension due to elevated pressure transmitted back through the pulmonary veins (Owan etal, 2006). Hypercapnea and hypoxia are potent causes of pulmonary hypertension in the perioperative setting.

Figure 5.

Contributing factors to hemodynamic instability in patients with DHF. Deviation from normal parameters can lead to either hypotension/reduced cardiac output, or to pulmonary edema. (Adapted with permission from Elsevier)


9. Management strategies

A summary of clinical strategies is shown in Figure 6. The mainstay of treatment is to be realistic about hemodynamic goals, and to return the patient to normal preoperative parameters. Potential reversible causes (particularly extrinsic causes) should be identified and managed like pericardial tamponade and significant pericardial effusion as they cause resistance to LV filling leading to acute DHF. These conditions should therefore be suspected in the event of unexplained DHF in the postoperative patient. Echocardiography is the most effective clinical tool to diagnose and monitor DHF. It can even gives indications about the hemodynamic profile of the patient, a raised left atrial pressure can be identified by enlarged atria, and a fixed curvature of the interatrial septum bowing from left to right (Royse et al 2001). One has to assess the different hemodynamic parameters of the patient to find out the cause for the imbalance that led to failure. For example, in the setting of reduced volume, administration of fluids, avoidance of tachycardia and reducing high dose inotropes will improve left ventricular end-diastolic volume. Vasoconstrictors may be required to counteract the effect of vasodilation which is seen during and immediately after cardiac surgery, thereby returning systemic vascular resistance to normal. Mechanical ventilation may affect hemodynamic performance in DHF. The mechanism is complex involving changes in preload and afterload for both right and left ventricles. Positive pressure ventilation may reduce venous return thereby reducing preload; and it also may reduce afterload enhancing ventricular ejection. This may have a variable effect on cardiac output. If the patient is normovolemic and intrathoracic pressure is normal, then the effect on afterload reduction may increase cardiac output. The beneficial effects of positive pressure ventilation on cardiac output are reversed by hypovolemia leading to decreased cardiac output and hypotension. Mechanical ventilation is beneficial in order to avoid hypercapnea, and PEEP can help reduce pulmonary venous congestion (Pinsky 2005, 2007). The use of continuous positive airway pressure (CPAP) by a face mask in the spontaneously breathing patient is reported to be effective in the treatment of diastolic dysfunction and may therefore be a useful ventilatory support under these circumstances (Benjelid etal, 2005; Moritz etal, 2003; Bersten etal, 1991)

Figure 6.

Strategies to treat DHF in the perioperative setting. Treatment strategies are aimed to return to preoperative parameters. RV is right ventricle, PEEP is positive end-expiratory pressure; CPAP is continuous positive airway pressure. (Adapted with permission from Elsevier)


10. The contributing factors

Acute renal failure leads to volume overload and can trigger DHF (Tsuyuki etal 2001) Excessive fluid administration has the same effect and can be a contributing factor for post operative DHF. Atrial fibrillation (AF) leads to loss of effective atrial contraction, changes LV filling pattern and results in a slowing of myocardial relaxation thereby triggering DHF. Pharmacological or electrical cardioversion may be necessary to restore sinus rhythm or at least rate control. In the postoperative coronary artery bypass patient unexplained DHF should lead to the suspicion of acute graft malfunction, which could happen in the absence of any signs of ischemia. Postoperative myocardial ischemia is an important reversible cause of diastolic dysfunction in the postoperative period as ischemia significantly slows active myocardial relaxation during early diastole affecting thereby LV filling. Ischemia could also lead to rhythm disturbances that will further aggravate LV diastolic dysfunction. It is well known that tachycardia and dysrhythmias shorten diastole leading to impaired left ventricular filling. Restoration of sinus rhythm should always be a priority in management (Zile & Brutstaert, (Piaarcchio 2002). If pacing is required, then atrio-ventricular sequential pacing will enhance ventricular filling. Ventricular pacing alone leads to loss of the atrial contribution (Alsaddique, 2008) and right ventricular pacing may induce dyssynchronous contraction. Pain may induce tachycardia and hypertension with the potential of triggering DHF through these mechanisms.Sepsis can exacerbate DHF, as it affects both systolic and diastolic function of the heart. In case of DHF developing late in the postoperative period sepsis should be considered as one of the possibilities. The role of sepsis in causing diastolic failure was identified by using pressure-volume loops in anesthetized endotoxemic rabbits. Left ventricular diastolic properties were shown to be altered; with prolonged relaxation, decreased compliance leading to increased end-diastolic pressure. Diastolic dysfunction can contribute to the development of cardiogenic septic shock (Pirracchio etal, 2007). Other factors that can contribute to DHF include a large pleural effusion or any other process that causes extrinsic compression of the heart or that could potentially impair or delay ventricular filling could contribute to or trigger DHF. This includes pericardial tamponade which is in effect “acute extrinsic DHF”.

11. Additional management considerations

The incidence of pure DHF in the postoperative heart in not known. Many cases of failure that are thought of as systolic failure are in reality diastolic in nature. There is no consensus on management of diastolic failure in the postoperative heart or intensive care environment in general. Echocardiography can be used not only to diagnose but also to monitor therapy and the hemodynamic changes. These points deserve emphasis:

  1. The management of DHF is based on the strategy of avoiding pulmonary congestion whilst maintaining adequate cardiac output, and correction of any predisposing factors. As the systolic function is maintained in diastolic failure positive inotropes have little role in the management. The exception is where there is “low normal” EF or evidence of RV dysfunction or RV strain in the setting of pulmonary hypertension. In these situations, low dose inotrope therapy may improve cardiac output and hemodynamic stability. High dose inotrope therapy will induce tachycardia, and shorten diastolic filling time, leading to progressive reduction in LV preload and deterioration in hemodynamics.

  2. In diastolic failure ventricular filling is impaired, diuretic therapy leads to volume depletion that will further impair ventricular filling resulting in a more reduction of the cardiac output.

  3. Vasodilation is the enemy of DHF. Though vasodilation facilitates ejection, the heart empties but is unable to adequately re-fill, leading to progressive reduction in preload and deterioration in hemodynamic conditions. Normalizing systemic vascular resistance with a vasoconstrictor helps to maintain hemodynamic stability and normotension.

  4. Many patients with DHF also have pulmonary hypertension. Hypotension in this setting leads to compromise of RV blood flow and relative RV ischemia, thereby causing RV failure. The RV fails by dilating, which leads to further compression of the LV and worsening DHF. This can lead to a spiral of progressive hypotension. In these circumstances a vasoconstrictor to preserve blood pressure and maintain LV preload, and in addition low dose inotrope (such as dobutamine) to support RV function, can improve hemodynamic stability. If the situation remains refractory it is worth considering nitric oxide (NO) to selectively treat right ventricular pressure overload. There is to our knowledge no published work on the use NO in DHF but it remains as an option if all else fails (Granton & Moric, 2008; Natori etal, 2003).

12. Use of diuretics

Diuretics should be used with caution, as high filling pressure is required to maintain cardiac output. Diuresis may result in hypotension in patients with DHF because of the steep shape of the left ventricular end-diastolic pressure-volume relationship, where small changes in end-diastolic volume will lead to reduced stroke volume. The use of diuretics must be countered by increased vigilance of hemodynamic variables, as indiscriminate use can be counter-productive (Zile & Burstaert, 2002; Aurigemma & Gaasch 2004).

13. Antiarrhythmics

Intravenous digoxin is a commonly used therapy for the management atrial fibrillation and paroxysmal atrial tachycardia. Other therapeutic agents include calcium antagonists such as verapamil, beta-blockers such as esmololol sotolol for acute rhythm control, or amiodarone. The current evidence supports the use of amiodarone for AF occurring after cardiac surgery. Amiodarone also reduces perioperative ventricular tachyarrhythmias and strokes, and helps reduce duration of hospitalization (Bagshaw etal,2006; Saltman, 2003). Nevertheless digoxin continues to be valuable in long-term therapy of atrial flutter and fibrillation. More recently digoxin has been the subject of different studies to determine its effects on all forms of heart failure (HF). It has been shown that digoxin at serum concentration of 0.5-0.9 ng/mL reduces mortality and hospitalizations in all HF patients, including those with DHF. At higher serum levels, digoxin reduces HF hospitalization but has no effect on mortality or all-cause hospitalizations (Ahmed etal, 2006). The recommendation went further to suggest that the results of the DIG trial may provide support for the use of digoxin in patients who have heart failure with preserved EF, because a trend toward reduction in hospitalizations for heart failure was observed with digoxin in the ancillary trial (Ahmed, 2006)]. However the guidelines of the American College of Cardiology–American Heart Association Task Force for the management of heart failure and the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology do not recommend the use of digoxin in patients who have heart failure with preserved EF (Hunt etal 2005; Swedberg etal, 2005).

13.1. Use of inotropes

Agressive use of positive inotropic agents have little role in the management of DHF, though low dose inotropes may improve stability in the setting of low-normal EF or where there is pulmonary hypertension as described earlier [such as a combination of 3-5mcg/kg/min dobutamine and norepinepherine 3-5 mcg/min] (Little & Brucks, 2005; Wu & Yu, 2005). This is a very common pattern in DHF in the perioperative setting and may be exaccerbated by poor cardioprotection (especially to the right heart), myocardial edema or reperfusion injury. Pharmacologically, the use of high dose inotropes leads to an increase in heart rate, which causes shortening of diastolic filling time leading to reduced ventricular volume and a gradual worsening of cardiac output. Therefore, in DHF it is probably wise to accept less than ideal hemodynamics provided adequate perfusion is maintained. It is therefore suggested that a cardiac index between 1.8 and 2.2 L.min.m-2 is acceptable. Aiming for higher levels of cardiac index may not be readily achieved, and the strategy used would necessitate higher doses of inotropes and volume, with potential for greater pulmonary venous congestion. The danger of increasing inotrope use is that if the patient deteriorates, the typical response is to increase the inotropic dose leading to further tachycardia and shortened diastolic filling, thereby further reducing stroke volume and worsening cardiac performance, effectively creating a vicious circle of deterioration. The art of managing these patients is to achieve the delicate balance between hypotension and pulmonary venous congestion by judicious use of vasopressors, low-dose inotropes and fluids, such that their baseline hemodynamic state is maintained until the recovery processes following surgery abate.

13.2. Role of Vasodilators

It is important to appreciate that vasodilators facilitate ventricular ejection, and in the setting of a stiff left ventricle, makes it difficult to re-fill. This is especially important if there is associated tachycardia, as this will further exacerbate the inability to adequately refill the ventricle. If vasodilators are used they could make the ventricle operates at a lower end-diastolic volume further contributing to the low cardiac output. Under these circumstances a vasoconstrictor may actually be helpful by reducing EF and increasing the end diastolic volume. Vasodilators (especially inodilators) are appropriate for secondary DHF (systolic and diastolic failure). It is important to remember, however, the goal of maintaining preoperative hemodynamics, which means that the level of vasodilation should not depart considerably from baseline. In practice, most patients will have a vasodilation state after surgery, and are already excessively dilated. Vasodilator use in this setting can be counterproductive. If using inodilators, then add norepinepherine to control excessive vasodilation, and return it towards normal.

13.3. Role of vasoconstrictors:

Vasoconstrictors should be considered as part of the management of DHF, if vasodilation is manifest in the postoperative course. Vasodilation is common both during and immediately after cardiac surgery, and is part of the sterile inflammatory response syndrome seen following cardiac surgery. Diastolic abnormality prevents adequate filling of the left ventricle so that the end-diastolic volume progressively declines. Low-dose vasoconstrictors are protective in this setting with the aim of normalizing but not increasing vascular resistance.

13.4. Other pharmacological agents.

The value of beta-blockers in the perioperative period has recently been questioned because of the POISE trial that has examined their effect on non-cardiac surgery patients (POISE study group, 2008). Nevertheless one could extrapolate that the same would probably happen in a cohort of cardiac surgery patients. Beta blockers offer cardiac protection in the shape of a reduction of myocardial infarction (Andersen etal, 2008; Everly etal, 2004). Conversely, the incidence of stroke and its resulting patient disability was increased in the treatment group leading to increased mortality (Sear etal, 2008). Caution should be exercised with aggressive use of perioperative beta blockade. Beta blockers in the postoperative heart are used for control of tachycardia in the presence of adequate volume. An ultra short acting agent given intravenously (e.g. esmolol or landiolol that have a very short half life can be helpful (Mitchell etal, 2002; Kirshenbaum etal 1985; Yoshida etal, 2008). They can also help in case of fast atrial fibrillation to achieve an initial rate control in the process of stabilizing the hemodynamics (Kobayashi etal, 2004). Verapamil, a calcium channel blocker, can also be used intravenously to control heart rate and to treat fast atrial fibrillation (Abernethy & Schwartz, 1999). Calcium channel blockers in general are effective in DHF caused by idiopathic hypertrophic cardiomyopathies (Setaro etal 1990), but they do not offer the same benefits to diastolic failure caused by other factors (Nishimura etal, 1993). There are no drugs specifically marketed for the treatment of diastolic dysfunction. Inodilators may improve diastolic function in systolic and DHF, or bi-ventricular failure, as they will maintain stroke volume at a lower left ventricular end-diastolic volume. This has the effect of the heart working at a lower end-diastolic pressure. Unloading of the right ventricle will reduce the effect of left ventricular compression via the interventricular septum.

Long-term (outpatient) treatment that addresses myocardial remodeling includes ACE-inhibitors and angiotensin receptor blockers, calcium channel blockers, careful use of diuretics such as spironolactone, carvidelol, control of hypertension and treatment of myocardial ischemia (Yip etal, 2008; Yamamoto etal, 2005;Bergstrom etal, 2004; Yoshhida etal, 2004) Future strategies are likely to address disorders of calcium handling, as well as modulating myocardial proteins and collagen subtypes (Kass etal, 2004)

13.5. Cardiac resynchronization therapy

Cardiac-resynchronization therapy (CRT) has been shown to improve the rate of survival, quality of life, exercise capacity, and functional status in patients with a prolonged QRS interval and moderate-to-severe heart failure that is resistant to optimal medical therapy. CRT is thought to improve the left ventricular EF and functional status by minimizing regional left ventricular delay caused by prolonged ventricular conduction, reducing mitral regurgitation and left ventricular reverse remodeling, and normalizing neurohormonal factors. Current guidelines support the use of CRT in patients with an EF of 35% or less, moderate or severe heart failure (New York Heart Association [NYHA] class III or IV), and a prolonged QRS interval [ 120 msec] (Abraham etal, 2002; (Leclercq etal, 2002). CRT did not improve peak oxygen consumption in patients with moderate-to-severe heart failure with narrow QRS intervals providing evidence these patients may not benefit from this form of therapy (Beshai etal, 2007). The effects on diastolic function have been the subject of recent studies by load-dependent pulsed-wave Doppler transmitral indices. A number of studies have shown that in heart failure patients receiving CRT, improvement in LV diastolic function is coupled to the improvement in LV systolic function (Waggoner etal, 2005). The specific value of CRT for the treatment of the DHF as distinct from systolic and diastolic failure has not however, been extensively investigated.

14. Summary

DHF is “ a small stiff heart” with high left atrial pressure, whereas systolic and diastolic failure is a dilated heart with reduced EF and a high left atrial pressure, and echocardiography is the best way to differentiate these two conditions.

The key operating principle in DHF is to maintain their preoperative haemodynamic state and maintain operating volume

The key operating principle of systolic and diastolic failure is to improve stroke volume at a lower operating volume

The cardiac index in DHF is not great - but is enough. Do not “shoot for the stars”.

Low dose inotropes and enough vasoconstrictors to normalise vascular resistance can improve hemodynamic stability

High dose inotropes are often counterproductive

Excessive vasodilation is the enemy of DHF.


  1. 1. AbernethyD. R.SchwartzJ. B.1999Calcium-antagonist drugs. N Engl J Med. 4;34119144757
  2. 2. AbrahamW. T.FisherW. G.SmithA. L.DelurgioD. B.LeonA. R.LohE.KocovicD. Z.PackerM.ClavellA. L.HayesD. L.EllestadM.TruppR. J.UnderwoodJ.PickeringF.TruexC.Mc AteeP.MessengerJ.2002MIRACLE Study Group. Multicenter In Sync Randomized Clinical Evaluation Cardiac resynchronization in chronic heart failure. N Engl Med. ;34624184553.
  3. 3. AhmedA.RichM. W.FlegJ. L.ZileM. R.YoungJ. B.KitzmanD. W.LoveT. E.AronowW. S.AdamsK. F.Jr GheorghiadeM2006Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation.;1145397403
  4. 4. AhmedA.RichM. W.LoveT. E.Lloyd-JonesD. M.AbanI. B.ColucciW. S.AdamsK. F.GheorghiadeM2006Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J. (2):178-86.
  5. 5. AlsaddiqueA. A.2008Recognition of diastolic heart failure in the postoperative heart. Eur J Cardiothorac Surg. Dec;34611418. Epub 2008 Jun 24
  6. 6. AlsaddiqueA. A.2008Recognition of diastolic heart failure in the postoperative heart, Eur J Cardiothorac Surg,doi:10.1016/j.ejcts.2008.05.030
  7. 7. AlsaddiqueA. A.RoyseA. G.RoyseC. F.FoudaM. A.2008Management of diastolic heart failure following cardiac surgery. Eur J Cardiothorac Surg. 2009 Feb;3522419. Epub Dec 11
  8. 8. AndersenS. S.HansenM. L.GislasonG. H.FolkeF.SchrammT. K.FosbølE.SørensenR.RasmussenS.AbildstrømS. Z.MadsenM.KøberL.Torp-PedersenC.2008Mortality and Reinfarction among Patients Using Different Beta-Blockers for Secondary Prevention after a Myocardial Infarction. Cardiology. 9;1122144150. [Epub ahead of print]
  9. 9. AppletonC. P.FirstenbergM. S.GarciaM. J.ThomasJ. D.2000The echo-Doppler evaluation of left ventricular diastolic function. A current perspective. Cardiol Clin.;1851346, ix
  10. 10. AppletonC. P.HatleL. K.PoppR. L.1988Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol.;1242640
  11. 11. AurigemmaG. P.GaaschW. H.2004Clinical practice. Diastolic heart failure. N Engl J Med. 9;351111097105.
  12. 12. BagshawS. M.GalbraithP. D.MitchellL. B.SauveR.ExnerD. V.GhaliW. A.2006Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg.;825192737
  13. 13. BailD. H.KoflerM.ZiemerG.2004Brain natriuretic peptide (BNP) in patients undergoing coronary artery bypass grafting. Thorac Cardiovasc Surg.;5213540
  14. 14. BendjelidK.SchützN.SuterP. M.FournierG.JacquesD.FarehS.RomandJ. A.2005Does continuous positive airway pressure by face mask improve patients with acute cardiogenic pulmonary edema due to left ventricular diastolic dysfunction? Chest. ;127310538
  15. 15. BenjaminE.GriffinK.LeibowitzA. B.ManasiaA.OropelloJ. M.GeffroyV.Del GiudiceR.HufandaJ.RosenS.GoldmanM.1998Goal-directed transesophageal echocardiography performed by intensivists to assess left ventricular function: comparison with pulmonary artery catheterization. J Cardiothorac Vasc Anesth. 1998 Feb;121105
  16. 16. BergstromA.AnderssonB.EdnerM.NylanderE.PerssonH.DahlstromU.2004Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 2004;6453461.
  17. 17. BernardF.DenaultA.BabinD.GoyerC.CoutureP.CouturierA.BuithieuJ.2001Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass. Anesth Analg. 2001;922918
  18. 18. BerstenA. D.HoltA. W.VedigA. E.SkowronskiG. A.BaggoleyC. J.1991Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med. 1991 26;32526182530
  19. 19. BeshaiJ. F.GrimmR. A.NaguehS. F.BakerJ. H.BeauS. L.GreenbergS. M.PiresL. A.TchouP. J.RethinQ.2007Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007;35724246171.
  20. 20. BhatiaR. S.TuJ. V.DSLeeAustin. P. C.FangJ.HaouziA.GongY.LiuP. P.2006Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med.2006355260
  21. 21. BoyerJ. K.ThanigarajS.SchechtmanK. B.PerezJ. E.2004Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004;93870875
  22. 22. BurkhoffD.MSMaurerPacker. M.2003Heart failure with a normal EF: is it really a disorder of diastolic function? Circulation. 2003; 11;10756568
  23. 23. MDCheitlinArmstrong. W. F.AurigemmaG. P.BellerG. A.BiermanF. Z.DavisJ. L.DouglasP. S.FaxonD. P.GillamL. D.KimballT. R.KussmaulW. G.ASPearlmanPhilbrick. J. T.RakowskiH.ThysD. M.2003ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol. 2003 Sep 3;42595470.
  24. 24. CoutureP.DenaultA. Y.ShiY.DeschampsA.CossetteM.PellerinM.TardifJ. C.2009Effects of anesthetic induction in patients with diastolic dysfunction. Can J Anaesth. 2009 May;56535765. Epub 2009 Apr 2
  25. 25. DeswalA.2005Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiology. Curr Cardiol Rep. 2005 ;7317883
  26. 26. DokainishH.2004Doppler tissue imaging in the evaluation of left ventricular diastolic function. Curr Opin Cardiol. 2004;1943741.
  27. 27. DraperN. J.ShahA. M.1997Beneficial effects of a nitric oxide donor on recovery of contractile function following brief hypoxia in isolated rat heart. J Mol Cell Cardiol. 1997;291195205
  28. 28. duToit. E. F.Mc CarthyJ.MiyashiroJ.OpieL. H.BrunnerF.1998Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischemic and reperfusion function of rat isolated hearts. Br J Pharmacol. 1998 ;123115967
  29. 29. DumesnilJ. G.GaudreaultG.HonosG. N.KingmaJ. G.1991Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol. 1991;685159
  30. 30. EltzschigH. K.RosenbergerP.LöfflerM.FoxJ. A.ArankiS. F.ShernanS. K.2008Impact of intraoperative transesophageal echocardiography on surgical decisions in 12,566 patients undergoing cardiac surgery. Ann Thorac Surg. 2008 Mar;85384552
  31. 31. EverlyM. J.HeatonP. C.CluxtonR. J.2004Beta-blocker underuse in secondary prevention of myocardial infarction. Ann Pharmacother. 2004 ;38228693.
  32. 32. GaaschW. H.ZileM. R.2004Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 2004;55373394.
  33. 33. GarciaM. J.ThomasJ. D.KleinA. L.1998New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol. 1998;3286575
  34. 34. MAGarcia-FernandezAzevedo. J.MorenoM.BermejoJ.Perez-CastellanoN.PuertaP.DescoM.AntoranzC.SerranoJ. A.GarciaE.DelcanJ. L.1999Regional diastolic function in ischaemic heart disease using pulse wave Doppler tissue imaging. Eur Heart J. 1999 Apr;207496505
  35. 35. GilbertJ. C.GlantzS. A.1989Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circ Res.;6482752
  36. 36. GrantonJ.MoricJ.2008Pulmonary Vasodilators-Treating the Right Ventricle. Anesthesiol Clin. 2008 ;262337353
  37. 37. GrobanL.DolinskiS. Y.2005Transesophageal echocardiographic evaluation of diastolic function. Chest. 2005 Nov;1285365263.
  38. 38. GrobanL.Diastolic dysfunction in the older heart.J Cardiothorac Vasc Anesth192282362005
  39. 39. HauserT. H.Mc ClennenS.KatsimaglisG.MEJosephsonManning. W. J.YeonS. B.2004Assessment of left atrial volume by contrast enhanced magnetic resonance angiography. J Cardiovasc Magn Reson. 2004;64917.
  40. 40. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular EF by the Heart Failure and Echocardiography Associations of theEuropean Society of Cardiology. Eur Heart J.282539502007
  41. 41. HuntS. A.AbrahamW. T.ChinM. H.FeldmanA. M.FrancisG. S.GaniatsT. G.JessupM.MAKonstamMancini. D. M.MichlK.OatesJ. A.RahkoP. S.MASilverStevenson. L. W.YancyC. W.AntmanE. M.SmithS. C.Jr AdamsC. D.AndersonJ. L.FaxonD. P.FusterV.HalperinJ. L.HiratzkaL. F.JacobsA. K.NishimuraR.OrnatoJ. P.PageR. L.RiegelB.2005American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society Circulation. 2005;112(12):e154235.
  42. 42. HuntS. A.BakerD. W.ChinM. H.CinquegraniM. P.FeldmanA. M.FrancisG. S.GaniatsT. G.GoldsteinS.GregoratosG.JessupM. L.NobleR. J.PackerM.MASilverStevenson. L. W.GibbonsR. J.AntmanE. M.AlpertJ. S.FaxonD. P.FusterV.JacobsA. K.HiratzkaL. F.RussellR. O.SmithS. C.2001American College of Cardiology/American Heart Association. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001 Dec;387210113
  43. 43. IribarrenC.KarterA. J.ASGoFerrara. A.LiuJ. Y.SidneyS.SelbyJ. V.Glycemic control and heart failure among adult patients with diabetes Circulation.1032001266873
  44. 44. KassD. A.BronzwaerJ. G.PaulusW. J.2004What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 2004;9415331542.
  45. 45. KawaguchiM.HayI.FeticsB.KassD. A.2003Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved EF: implications for systolic and diastolic reserve limitations. Circulation. 2003;10771420
  46. 46. KayH. R.AfshariM.BarashP.WeblerW.IskandrianA.BemisC.HakkiA. H.MundthE. D.1983Measurement of ejection fraction by thermal dilution techniques. J Surg Res. 1983;3433746
  47. 47. KhouriS. J.MalyG. T.SuhD. D.WalshT. E.2004A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr. 2004;172907
  48. 48. KirshenbaumJ. M.KlonerR. A.AntmanE. M.BraunwaldE.1985Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. Circulation. 1985 ;72487380
  49. 49. KitzmanD. W.LittleW. C.BrubakerP. H.AndersonR. T.HundleyW. G.MarburgerC. T.BrosnihanB.MorganT. M.StewartK. P.2002Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. Jama 2002;28821442150.
  50. 50. KlapholzM.MaurerM.LoweA. M.MessineoF.MeisnerJ. S.MitchellJ.KalmanJ.PhillipsR. A.SteingartR.BrownE. J.JrBerkowitzR.MoskowitzR.SoniA.ManciniD.BijouR.SehhatK.VarshneyaN.KukinM.KatzS. D.SleeperL. A.Le JemtelT. H.2004Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 2004;4314321438.
  51. 51. KleinA. L.CanaleM. P.RajagopalanN.WhiteR. D.MurrayR. D.WahiS.ArheartK. L.ThomasJD1999Role of transesophageal echocardiography in assessing diastolic dysfunction in a large clinical practice: a 9 -year experience. Am Heart J. 1999 Nov;138(5 Pt 1):880-9
  52. 52. KloetersC.DusheS.DohmenP. M.MeyerH.KrugL. D.HermannK. G.HammB.KonertzW. F.2008Evaluation of left and right ventricular diastolic function by electron-beam computed tomography in patients with passive epicardial constraint. J Comput Assist Tomogr. 2008 Jan-Feb;3217885
  53. 53. KobayashiM.MachidaN.MitsuishiM.YamaneY.2004Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure. Am J Hypertens 2004;1711121119.
  54. 54. KostisJ. B.DavisB. R.CutlerJ.GrimmR. H.JrBergeK. G.JDCohenLacy. C. R.PerryH. M.JrMDBlaufox-SmollerWassertheil.BlackS.SchronH. R.BerksonE.CurbD. M.JDSmithW. M.Mc DonaldR.ApplegateW. B.1997Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. Jama 1997;278212216.
  55. 55. KrishnaswamyP.LubienE.CloptonP.KoonJ.KazanegraR.WannerE.GardettoN.GarciaA.De MariaA.2001AS Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med. 2001 Sep;11142749
  56. 56. KusumotoF. M.MuhiudeenI. A.KuechererH. F.CahalanM. K.SchillerN. B.1993Response of the interatrial septum to transatrial pressure gradients and its potential for predicting pulmonary capillary wedge pressure: an intraoperative study using transesophageal echocardiography in patients during mechanical ventilation J Am Coll Cardiol. 1993;217218.
  57. 57. LeclercqC.KassD. A.2002Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002;39194201
  58. 58. LewisB. S.GotsmanM. S.1976Left ventricular diastolic pressure-volume relations in man S Afr Med J. 1976;50971
  59. 59. LittleW. C.BrucksS.2005Therapy for diastolic heart failure. Prog Cardiovasc Dis. 2005;4763808.
  60. 60. LiuJ. E.PalmieriV.MJRomanBella. J. N.FabsitzR.HowardB. V.WeltyT. K.LeeE. T.DevereuxR. B.2001The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol. 2001;3719439
  61. 61. LubienE.De MariaA.KrishnaswamyP.CloptonP.KoonJ.KazanegraR.GardettoN.WannerE.MaiselAS2002Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation. 2002 Feb 5;1055595601.
  62. 62. LukowiczT. V.FischerM.HenseH. W.DöringA.StritzkeJ.RieggerG.SchunkertH.LuchnerA.2005MONICA Investigators. BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy. Eur J Heart Fail. 2005 Jun;7452531.
  63. 63. ASMaiselKrishnaswamy. P.NowakR. M.Mc CordJ.HollanderJ. E.DucP.OmlandT.StorrowA. B.AbrahamW. T.WuA. H.CloptonP.StegP. G.WestheimA.KnudsenC. W.PerezA.KazanegraR.HerrmannH. C.Mc CulloughP. A.2002Breathing Not Properly Multinational Study Investigators Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002 Jul 18;34731617
  64. 64. MitchellR. G.StoddardM. F.Ben-YehudaO.AggarwalK. B.AllenbyK. S.TrilloR. A.LoydR.ChangC. T.LabovitzA. J.2002Esmolol in acute ischemic syndromes. Am Heart J. 2002;144(5):E9
  65. 65. MoritzF.BenichouJ.VanhesteM.RichardJ. C.LineS.HellotM. F.BonmarchandG.MullerJ. M.2003Boussignac continuous positive airway pressure device in the emergency care of acute Eur J Emerg Med. 2003 ;1032048
  66. 66. MottramP. M.BAHaluskaLeano. R.CarlierS.CaseC.MarwickT. H.2005Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart. 2005;9115516
  67. 67. MyślińskiW.MosiewiczJ.BiłanA.MakarukB.JaszynaM.HanzlikJ.2002Prognostic value of the atrial pulsed Doppler recordings of transmitral flow in the assessment of left ventricular diastolic dysfunction. Ann Univ Mariae Curie Sklodowska [Med]. 2002;572332
  68. 68. NatoriS.HasebeN.JinY. T.MatsusakaT.IdoA.MatsuhashiH.IharaT.KikuchiK.2003Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure. Am J Respir Crit Care Med. 2003 15;1676895901
  69. 69. NihoyannopoulosP.FoxK.FraserA.PintoF.2007Laboratory Accreditation Committee of the EAE EAE laboratory standards and accreditation. Eur J Echocardiogr. 2007 Jan;81807
  70. 70. NishimuraR. A.SchwartzR. S.HolmesD. R.TajikA. J.1993Failure of calcium channel blockers to improve ventricular relaxation in humans. J Am Coll Cardiol. 1993;2111828
  71. 71. OnoseY.OkiT.TabataT.YamadaH.1999Assessment of the temporal relationship between left ventricular relaxation and filling during early diastole using pulsed Doppler echocardiography and Doppler tissue imaging. Jpn Circ J. 1999;6320915
  72. 72. OtasevićP.NeskovićA. N.PopovićZ.VlahovićA.BojićD.BojićM.PopovićA. D.2001Short early filling deceleration time on day 1 after acute myocardial infarction is associated with short and long term left ventricular remodeling. Heart. 2001 May;85552732
  73. 73. OwanT. E.HodgeD. O.HergesR. M.JacobsenS. J.RogerV. L.RedfieldM. M.2006Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;3552519
  74. 74. PinskyM. R.2005Cardiovascular issues in respiratory care. Chest. 2005;128(5 Suppl 2):592S-597S
  75. 75. PinskyM. R.2007Heart-lung interactions Curr Opin Crit Care. 2007;13552831.
  76. 76. PirracchioR.CholleyB.De HertS.SolalA. C.MebazaaA2007Diastolic heart failure in anaesthesia and critical care. Br J Anaesth. 2007;9870721.
  77. 77. StudyP. O. I. S. E.GroupDevereaux. P. J.YangH.YusufS.GuyattG.LeslieK.VillarJ. C.XavierD.ChrolaviciusS.GreenspanL.PogueJ.PaisP.LiuL.XuS.MálagaG.AvezumA.ChanM.MontoriV. M.JackaM.ChoiP.2008Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet. 2008 31;3719627183947.
  78. 78. RademakersF. E.BogaertJ.2006Cardiac dysfunction in heart failure with normal ejection fraction: MRI measurements. Prog Cardiovasc Dis. 2006;4921527
  79. 79. RademakersF. E.2003Magnetic resonance imaging in cardiology. Lancet 2003;361359360.
  80. 80. RakusanK.CicuttiN.KolarF.2001Effect of anemia on cardiac function, microvascular structure, and capillary hematocrit in rat hearts. Am J Physiol Heart Circ Physiol. 2001;280:H140714
  81. 81. RoyseC. F.RoyseA. G.BharatulaA.LaiJ.VeltmanM.CopeL.KumarA2004Substernal epicardial echocardiography: a recommended examination sequence and clinical evaluation in patients undergoing cardiac surgery. Ann Thorac Surg.786139; discussion 619.
  82. 82. RoyseC. F.RoyseA. G.SoedingP. F.BlakeD. W.2001Shape and movement of the interatrial septum predicts change in pulmonary capillary wedge pressure. Ann Thorac Cardiovasc Surg 2001;77983.
  83. 83. RumbergerJ. A.2000Use of electron beam tomography to quantify cardiac diastolic function. Cardiol Clin. 2000 Aug;18354756
  84. 84. SalemR.DenaultA. Y.CoutureP.BélisleS.FortierA.GuertinM. C.CarrierM.MartineauR.2006Left ventricular end-diastolic pressure is a predictor of mortality in cardiac surgery independently of left ventricular ejection fraction. Br J Anaesth. 2006;972927.
  85. 85. SaltmanA. E.2003Is it time to choose amiodarone for postoperative atrial fibrillation? J Thorac Cardiovasc Surg. 2003;125612023
  86. 86. SandersD.DudleyM.GrobanL.2009Diastolic dysfunction, cardiovascular aging, and the anesthesiologist. Anesthesiol Clin. 2009 Sep;273497517Anesthesiol Clin. 2009 Sep;27(3):497-517
  87. 87. SchlüterK. D.WeberM.SchravenE.PiperH. M.1994NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action Am J Physiol. 1994;267:H14616.
  88. 88. SearJ. W.GilesJ. W.Howard-AlpeG.FoëxP.2008Perioperative beta-blockade, 2008: what does POISE tell us, and was our earlier caution justified? Br J Anaesth. 2008 ;10121358.
  89. 89. SetaroJ. F.ZaretB. L.SchulmanD. S.BlackH. R.SouferR.1990Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol. 1990 ;66129816.
  90. 90. ShahP. M.PaiR. G.1992Diastolic heart failure. Curr Probl Cardiol. 1992 Dec;1712781868.
  91. 91. SibleyC. T.LimaJ. A.2008Assessment of ventricular structure and function with multidetector CT and MRI. Curr Cardiol Rep. 2008 Feb;1016771
  92. 92. SiniscalchiA.PavesiM.PiracciniE.De PietriL.BragliaV.Di BenedettoF.LauroA.SpedicatoS.DanteA.PinnaA. D.FaenzaS.2005Right ventricular end-diastolic volume index as a predictor of preload status in patients with low right ventricular ejection fraction during orthotopic liver transplantation. Transplant Proc. 2005;3725413
  93. 93. SohnD. W.ChaiI. H.LeeD. J.KimH. C.KimH. S.OhB. H.LeeM. M.ParkY. B.ChoiY. S.SeoJ. D.LeeY. W.1997Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997;3047480
  94. 94. SongM. H.KobayashiY.MichiH.2004Clinical implication of atrial and brain natriuretic Peptide in coronary artery bypass grafting. Asian Cardiovasc Thorac Ann. 2004;12416.
  95. 95. SpinaleF. G.ZellnerJ. L.MukherjeeR.CrawfordF. A.1991Placement considerations for measuring thermodilution right ventricular ejection fractions. Crit Care Med. 1991;1941721.
  96. 96. SpinaleF. G.ZellnerJ. L.MukherjeeR.FerrisS. E.CrawfordF. A.1990Thermodilution right ventricular ejection fraction. Catheter positioning effects. Chest. 1990;98125965
  97. 97. StewartR. A.2005Broader indications for B-type natriuretic peptide testing in coronary artery disease. Eur Heart J. 2005;262079
  98. 98. SwedbergK.ClelandJ.DargieH.DrexlerH.FollathF.KomajdaM.TavazziL.SmisethO. A.GavazziA.HaverichA.HoesA.JaarsmaT.KorewickiJ.LévyS.LindeC.Lopez-SendonJ. L.MSNieminenPiérard. L.RemmeW. J.2005Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J.200511111540.
  99. 99. TemporelliP. L.GiannuzziP.NicolosiG. L.LatiniR.FranzosiM. G.GentileF.TavazziL.MaggioniA. P.2004GISSI-3 Echo Substudy Investigators. Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 echo sub study. J Am Coll Cardiol. 2004 May 5;439164653
  100. 100. TsuyukiR. T.Mc KelvieR. S.ArnoldJ. M.AvezumA.BarrettoA. C.CarvalhoA. C.IsaacD. L.KitchingA. D.PiegasL. S.TeoK. K.YusufS.2001Acute precipitants of congestive heart failure exacerbations. Arch Intern Med. 2001;161233742
  101. 101. TsuyukiR. T.Mc KelvieR. S.ArnoldJ. M.AvezumA.BarrettoA. C.CarvalhoA. C.IsaacD. L.KitchingA. D.YusufS.2001Acute precipitants of congestive heart failure exacerbations. Arch Intern Med. 2001;161211527
  102. 102. van HeerebeekL.BorbélyA.NiessenH. W.BronzwaerJ. G.van der VeldenJ.StienenG. J.LinkeW. A.LaarmanG. J.PaulusW. J.2006Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006 25;113196673.
  103. 103. van KraaijD. J.van PolP. E.RuitersA. SwartJ. B.LipsD. J.LencerN.DoevendansP. A.2002Diagnosing diastolic heart failure. Eur J Heart Fail. 2002 Aug;4441930.
  104. 104. VasanR. S.BenjaminE. J.LevyD.1995Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;2615651574
  105. 105. VasanR. S.LevyD.2000Defining diastolic heart failure: a call for standardized diagnostic criteria.Circulation2000;101211821
  106. 106. VasanR. S.2003Diastolic heart failure. BMJ. 2003 Nov 22;327742511812
  107. 107. VignonP.2005Hemodynamic assessment of critically ill patients using echocardiography Doppler. Curr Opin Crit Care. 2005 Jun;11322734
  108. 108. VitarelliA.Gheorghiade1998(1998) Diastolic heart failure: standard Doppler approach and beyond. Am J Cardiol. 1998 Jun 18;81(12A):115G-121G.
  109. 109. WaggonerA. D.FaddisM. N.MJGleva delas.FuentesL.Dávila-RománV. G.2005Improvements in left ventricular diastolic function after cardiac resynchronization therapy are coupled to response in systolic performance. J Am Coll Cardiol. 2005 ;461222449
  110. 110. WaggonerA. D.FaddisM. N.MJGleva DeLas.FuentesL.OsbornJ.HeuermanS.Davila-RomanV. G.2005Cardiac resynchronization therapy acutely improves diastolic function. J Am Soc Echocardiogr. 2005;18321620
  111. 111. WhalleyG. A.GambleG. D.DoughtyR. N.2006Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies. Heart. 2006 Nov;9211158894.
  112. 112. WuE. B.YuC. M.2005Management of diastolic heart failure--a practical review of pathophysiology and treatment trial data. Int J Clin Pract. 2005 ;5910123946
  113. 113. YamamotoK.ManoT.YoshidaJ.SakataY.NishikawaN.NishioM.OhtaniT.HoriM.MiwaT.MasuyamaT.2005ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. J Hypertens 2005;23393400.
  114. 114. YipG. W.WangM.WangT.ChanS.FungJ. W.YeungL.YipT.LauS. T.CPLauTang. M. O.YuC. M.SandersonJ. E.2008The Hong Kong diastolic heart failure study: a randomized controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal EF. Heart 2008;94573580.
  115. 115. YoshidaJ.YamamotoK.ManoT.SakataY.NishikawaN.NishioM.OhtaniT.MiwaT.HoriM.MasuyamaT.2004AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Hypertension 2004;43686691.
  116. 116. YoshidaY.TerajimaK.SatoC.AkadaS.MiyagiY.HongoT.TakedaS.TanakaK.SakamotoA.2008Clinical role and efficacy of landiolol in the intensive care unit J Anesth. 2008;221649.
  117. 117. ZileM. R.BaicuC. F.GaaschW. H.2004Diastolic heart failure-- abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004;35019531959.
  118. 118. ZileM. R.BrutsaertD. L.2002New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002;10515031508.
  119. 119. ZileM. R.BrutsaertD. L.2002New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002;105138793
  120. 120. ZileM. R.GaaschW. H.CarrollJ. D.FeldmanM. D.AurigemmaG. P.SchaerG. L.GhaliJ. K.LiebsonP. R.2001Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 2001;10477982

Written By

Juan Lacalzada, Amelia Duque, Alejandro de la Rosa, Antonio Barragan, María Manuela Izquierdo, Eduardo Arroyo, Ana Laynez and Ignacio Laynez

Submitted: November 11th, 2010 Published: July 5th, 2011